Crescent Biopharma, Inc. · NASDAQ:CBIO

Fairmount Funds Management LLC reported a 18.53% stake in Crescent Biopharma, Inc. (Schedule 13D/A)

Event Dec 4, 2025 · Filed Dec 8, 2025

Fairmount Funds Management LLC reported a 18.53% stake in Crescent Biopharma, Inc., 5,643,482 shares, with active intent on Dec 4, 2025. Filed Dec 8, 2025 (Schedule 13D/A).

Stake
18.53%
Shares
5,643,482
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Fairmount Funds Management LLC18.53%5,643,482
Fairmount Healthcare Fund II L.P.18.53%5,643,482
Peter Evan Harwin18.53%5,643,482
Tomas Kiselak18.53%5,643,482

Source

View original at SEC

Related